Online ISSN: 2331-4737
www.oncoscience.us
About Oncoscience
Our mission is to cover the rapidly growing field of cancer research. We aim to focus on emergent topics not currently covered by other journals.
Oncoscience has also a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors.

LEARN MORE ABOUT ONCOSCIENCE

Management of Recurrent Gastrointestinal Cancer with Ripretinib and Surgery

News

November 3, 2023
PRESS RELEASE: On September 20, 2023, a new case report was published in Oncoscience, entitled, “Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.” continue reading »

Diagnosis and Management of Postoperative Wound Infections in the Head and Neck Region

News

October 20, 2023
PRESS RELEASE: On October 4, 2023, a new research perspective was published in Oncoscience, entitled, “Diagnosis and management of postoperative wound infections in the head and neck region.” continue reading »

Behind the Study: Global Pandemic Exit Strategy: Equity and Immunity

Oncoscience

October 16, 2023
Dr. Lennard YW Lee, Yuxin Ying and Jola Bytyci from the University of Oxford, UK, elaborate on a recent editorial they co-authored that was published by Oncoscience in Volume 10, entitled, “Exiting the pandemic together: achieving global immunity and equity.” continue reading »

Lurbinectedin for Neuroendocrine Tumors (NETs)

News

October 6, 2023
PRESS RELEASE: On June 14, 2023, a new editorial was published in Oncoscience, entitled, “Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer.” continue reading »